IQVIA 23 avr. 2026 The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
IQVIA 13 mars 2026 Expanding Options for Emerging Biopharma in the U.S.: A conversation with Meg Hooton, IQVIA Biotech - IQVIA